3rd Annual Kenneth D. Hatch, MD Memorial Lectureship 2024

Wednesday, October 16, 2024, 7:00 AM - 10:30 AM, Health Innovation Sciences Buildering (HISB) Forum, 1670 E. Drachman St., Tucson, AZ


AMA PRA Category 1 Credits™ (3.00 hours), Non-Physician Attendance (3.00 hours)

The 3rd Annual Kenneth D. Hatch Memorial Lectureship is a CME activity regarding OBGYN to honor the memory of Dr. Hatch's immense talents in advanced laparoscopy and vaginal surgery, as well as in his role as a mentor to residents and medical trainees. Dr. Hatch has touched the lives of so many people, his residents and visiting trainees, his faculty and colleagues here and around the world, his friends and family, and last - but not least - his patients. The purpose of this lectureship in his honor is to memorialize his unique talent for educating all of us, and to share with those who may have missed out on learning directly from him in the OR, his immense talents in advanced laparoscopy and vaginal surgery. Please join us for an exciting morning of CME topics related to cervical cancer.

Registration Fees: None, free event

1. Counsel patients on potential treatments for early cervical cancer and on chemoradiation treatments for more advanced cervical cancer.
2. Incorporate into practice knowledge of pathognomonic signs of colposcopy for diagnosing HSIL as appropriate.
3. Utilize modified technique of cervical biopsy and loop excision as appropriate.
4. Employ vaginally-assisted laparoscopic surgery as appropriate for women diagnosed with early stage cervical cancer.
5. Improve delivery of bad news to women diagnosed with cervical neoplasia.
6. Employ the current standard of care using chemoradiation.
7. Utilize brachytherapy as appropriate.
8. Utilize advances in radiation technology to improve outcomes.
9. Improve ability to work as a team and use time efficiently.
10. Incorporate into practice awareness of disparities that exist in cervical cancer screening, stage at diagnosis, treatment, and mortality.
11. Describe barriers to cervical cancer screening and other factors that contribute to differences in cervical cancer prognosis and survival rate.
12. Identify strategies to address disparities in the prevention and treatment of cervical cancer.

The University of Arizona College of Medicine - Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Arizona College of Medicine - Tucson designates this Live Activity for a maximum of 3.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Cancellation Policy

 The organization holding the activity reserves the right to cancel or postpone this program if necessary; in the event of cancellation, registration fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement

University of Arizona College of Medicine - Tucson Office of Continuing Medical Education is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME activity coordinator.

You are not logged in.

Please click the button below to login or create a new account before continuing.

Mitigation of Relevant Financial Relationships

University of Arizona College of Medicine - Tucson Office of Continuing Medical Education adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests). The CME office reviewers have nothing to disclose. All relevant financial relationships have been mitigated prior to the commencement of the activity.